MedPath

Effect of Unani drug on Dyslipidemia

Phase 2
Conditions
Health Condition 1: I998- Other disorder of circulatory system
Registration Number
CTRI/2020/09/027924
Lead Sponsor
ational Institute of Unani Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Known cases of Dyslipidemia with disease history of < 3yrs with or without anti hyperlipidemic medication.

Total Cholesterol > 200- 239mg / dl27

Triglycerides < 499 mg / dl (High)

LDL >189 mg / dl27

HDL < 40 mg / dl in men and <50 woman27

VLDL >0.930â??1.006 g/ L5

Ratio HDL to LDL < 6.3 in men and 5 in woman

Patients of both sex

Age: between 20-50 yrs

BMI <=39.929

Known cases of DM type -2 with Dyslipidemia

Fasting blood sugar (FBS) > 126 mg/dl - < 150mg/dl30

Post Prandial blood sugar (PPBS) > 140 mg/dl - < 250mg/dl 5

Normotensives ( < 130 â?? 80 mm of Hg)

Patients who follow the protocol

Exclusion Criteria

Known cases of Dyslipidemia, with disease history of > 3yrs

Total Cholesterol > 240 mg / dl

Triglycerides > 499 mg / dl (High)27

LDL < 189 mg / dl 31

HDL > 70 mg / dl

VLDL <0.930â??1.006 g/L

Ratio LDL to HDL >6.3 in men and >5 in woman

Known cases of Type 2 Diabetes Mellitus with complications.

Fasting Blood Sugar >150 mg/dl32

Post Prandial blood sugar (PPBS) > 250mg/dl

Known cases of Hypertension 33Diabetes Mellitus type I, Hypothyroidism

Known cases on use of corticosteroids, and contraceptives.

History of cardiovascular, Renal, Liver diseases, AIDS and T.B.

History of alcoholism

BMI >= 40

Pregnant & lactating mothers

Age < 20 and > 50 years of age

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Changes in Lipid profileTimepoint: 8 weeks
Secondary Outcome Measures
NameTimeMethod
ilTimepoint: Nil
© Copyright 2025. All Rights Reserved by MedPath